Display options
Cite
Panyatip P, Nunthaboot N, Puthongking P. . Int J Tryptophan Res. 2020;13:1178646920978245doi: 10.1177/1178646920978245.
Panyatip, P., Nunthaboot, N., & Puthongking, P. (2020). . International journal of tryptophan research : IJTR, 131178646920978245. https://doi.org/10.1177/1178646920978245
Panyatip, Panyada, et al. "." International journal of tryptophan research : IJTR vol. 13 (2020): 1178646920978245. doi: https://doi.org/10.1177/1178646920978245
Panyatip P, Nunthaboot N, Puthongking P. . Int J Tryptophan Res. 2020 Dec 15;13:1178646920978245. doi: 10.1177/1178646920978245. eCollection 2020. PMID: 33402831; PMCID: PMC7745548.
Copy Download .nbib Format: NLM
Share it on

Int J Tryptophan Res. 2020 Dec 15;13:1178646920978245. doi: 10.1177/1178646920978245. eCollection 2020.

[No title available]

International journal of tryptophan research : IJTR

Panyada Panyatip, Nadtanet Nunthaboot, Ploenthip Puthongking

Affiliations

  1. Graduate School, Khon Kaen University, Khon Kaen, Thailand.
  2. Melatonin Research Group, Khon Kaen University, Khon Kaen, Thailand.
  3. Center of Excellence for Innovation in Chemistry (PERCH-CIC), Faculty of Science, Mahasarakham University, Maha Sarakham, Thailand.
  4. Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, Khon Kaen University, Khon Kaen, Thailand.

PMID: 33402831 PMCID: PMC7745548 DOI: 10.1177/1178646920978245

Abstract

Melatonin (MLT) is a well-known pineal hormone possessed with remarkable biological activities. However, its low oral bioavailability and high first-pass metabolism rate are important pharmacokinetics problems. Therefore, 5 MLT derivatives (

© The Author(s) 2020.

Keywords: ADME; Melatonin; N-amide derivative; metabolism; molecular docking

Conflict of interest statement

Declaration of conflicting interests:The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

References

  1. Toxicology. 1999 Nov 29;139(1-2):53-79 - PubMed
  2. Int J Mol Sci. 2016 Dec 16;17(12): - PubMed
  3. J Pineal Res. 2010 May;48(4):297-310 - PubMed
  4. Drug Metab Dispos. 2005 Apr;33(4):489-94 - PubMed
  5. Sci Rep. 2017 Mar 03;7:42717 - PubMed
  6. J Comput Chem. 2010 Jan 30;31(2):455-61 - PubMed
  7. Clin Pharmacokinet. 1981 Jul-Aug;6(4):245-58 - PubMed
  8. J Pineal Res. 2007 Nov;43(4):317-20 - PubMed
  9. Drug Res (Stuttg). 2016 Apr;66(4):169-73 - PubMed
  10. J Mol Recognit. 2016 Aug;29(8):370-90 - PubMed
  11. J Pineal Res. 2019 Jan;66(1):e12531 - PubMed
  12. J Pineal Res. 2001 Nov;31(4):333-42 - PubMed
  13. Acta Pharmacol Sin. 2006 Jan;27(1):41-9 - PubMed
  14. Pharm Res. 2002 Oct;19(10):1446-57 - PubMed
  15. Drug Discov Today Technol. 2004 Dec;1(4):337-41 - PubMed
  16. J Comput Chem. 2004 Oct;25(13):1605-12 - PubMed
  17. J Med Chem. 2002 Jun 6;45(12):2615-23 - PubMed
  18. J Biol Chem. 2007 May 11;282(19):14348-55 - PubMed
  19. Clin Pharmacol Ther. 2001 Jul;70(1):10-6 - PubMed
  20. J Comput Aided Mol Des. 1996 Aug;10(4):293-304 - PubMed
  21. Drug Metab Dispos. 1998 Mar;26(3):261-6 - PubMed
  22. Front Endocrinol (Lausanne). 2019 Jul 16;10:480 - PubMed
  23. Eur J Clin Pharmacol. 2001 Mar;56(12):881-8 - PubMed

Publication Types